ClinicalTrials.Veeva

Menu

ANalyzing Olfactory Dysfunction Mechanisms In COVID-19 (ANOSMIC-19)

U

Universitaire Ziekenhuizen KU Leuven

Status

Enrolling

Conditions

SARS-CoV-2

Treatments

Other: Sampling of tissue

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

We aim to understand the mechanism of olfactory dysfunction in COVID-19.

Full description

In December 2019, a new coronavirus causing severe acute respiratory syndrome was described in Wuhan, China. This virus, later named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), spread worldwide and has been designated a pandemic by the World Health Organization.

By the beginning of March 2020, several Ear, Nose, Throat societies raised awareness of a frequent association between coronavirus disease 2019 (COVID-19) and smell disorders.

In the present study, the investigators wish to begin to understand the pathogenesis of olfactory dysfunction in COVID-19.

Enrollment

150 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Deceased hospitalised patients, tested positive or negative for SARS-CoV-2 for patient or control group respectively

Exclusion criteria

  • none

Trial design

Primary purpose

Basic Science

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

150 participants in 1 patient group

COVID-19 positive or negative patients
Other group
Description:
Hospitalised patients with or without COVID-19 (with or without olfactory dysfunctions)
Treatment:
Other: Sampling of tissue

Trial contacts and locations

1

Loading...

Central trial contact

Marnick Clijsters; Laura Van Gerven

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems